http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3088322-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca21c29aaa0f8648acd7434e56b839c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b27af1a36e0669f797304e74fec3bb6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f50dc4a5a5ee5828c97b72383f2367c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a4d2e555f4deecfbccc0cb24f039c18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D229-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-3442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01C1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D229-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
filingDate 2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c68520b28ea0c7ba886cfa6f4f52c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5f9675ca82e568bd4e66185aeb03d5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df5bcfc438a300b59341ad50b85a552a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05cafa3f6dc87cca5a54b4403e50d74
publicationDate 2020-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-3088322-A1
titleOfInvention NEW SYNTHESIS PATHWAY OF DIAZIRINS, ENRICHED OR NON-NITROGEN-15
abstract The present invention relates to a new process for the synthesis of diazirines, enriched or not with nitrogen-15, from amino acids or imines via a synthesis method in a single pot, comprising the reaction of the amino acid or l starting imine with ammonia, enriched or not with nitrogen-15, and an oxidant with hypervalent iodine. The present invention also relates to a process for the synthesis of ammonia enriched in nitrogen-15. An object of the invention relates to certain diazirines of formula (I) capable of being obtained by the claimed synthetic process and another object refers to the 15N2-diazrines of formula (I '). The claimed diazirines can be used in photoaffinity labeling. 15N2-diazirines can also be used in hyperpolarization in the field of medical imaging in particular.
priorityDate 2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014081391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016096897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017045891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016049123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010076490-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421665873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163707359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465365456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14248197

Total number of triples: 31.